D

Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192

Watchlist Manager
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Watchlist
Price: 45.1 CNY -3.34% Market Closed
Market Cap: 18.7B CNY
Have any thoughts about
Dizal Jiangsu Pharmaceutical Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Dizal Jiangsu Pharmaceutical Co Ltd

Current Assets 910.4m
Cash & Short-Term Investments 748.2m
Receivables 85.5m
Other Current Assets 76.6m
Non-Current Assets 586m
PP&E 104.8m
Intangibles 462m
Other Non-Current Assets 19.2m
Current Liabilities 448.4m
Accounts Payable 108.9m
Accrued Liabilities 57.5m
Short-Term Debt 201.8m
Other Current Liabilities 80.2m
Non-Current Liabilities 199.3m
Long-Term Debt 187.2m
Other Non-Current Liabilities 12.1m

Balance Sheet
Dizal Jiangsu Pharmaceutical Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
30
207
509
364
122
70
Cash
0
0
0
364
122
70
Cash Equivalents
30
207
509
0
0
0
Short-Term Investments
212
12
90
1 711
1 295
679
Total Receivables
22
10
8
9
9
86
Accounts Receivables
22
10
7
8
0
48
Other Receivables
0
0
1
1
0
38
Inventory
0
0
0
0
5
23
Other Current Assets
5
15
18
28
42
53
Total Current Assets
270
244
625
2 112
1 473
910
PP&E Net
9
17
15
105
106
105
PP&E Gross
9
17
15
105
106
105
Accumulated Depreciation
1
4
9
30
54
83
Intangible Assets
346
327
506
475
492
462
Note Receivable
16
39
32
50
3
2
Other Long-Term Assets
0
0
4
5
8
17
Total Assets
640
N/A
627
-2%
1 182
+88%
2 746
+132%
2 082
-24%
1 496
-28%
Liabilities
Accounts Payable
58
128
65
132
153
109
Accrued Liabilities
12
21
28
34
50
58
Short-Term Debt
0
0
0
2
2
202
Current Portion of Long-Term Debt
0
0
0
17
21
23
Other Current Liabilities
26
28
10
27
22
57
Total Current Liabilities
96
177
103
212
248
448
Long-Term Debt
0
0
0
71
64
187
Other Liabilities
0
0
0
0
11
12
Total Liabilities
96
N/A
177
+84%
103
-42%
283
+174%
323
+14%
648
+100%
Equity
Common Stock
743
1 095
360
404
407
408
Retained Earnings
199
645
0
670
1 406
2 514
Additional Paid In Capital
0
0
719
2 729
2 757
2 954
Total Equity
544
N/A
450
-17%
1 079
+140%
2 463
+128%
1 758
-29%
849
-52%
Total Liabilities & Equity
640
N/A
627
-2%
1 182
+88%
2 746
+132%
2 082
-24%
1 496
-28%
Shares Outstanding
Common Shares Outstanding
400
400
400
404
407
408

See Also

Discover More